Full Text View
Tabular View
No Study Results Posted
Related Studies
The Comparison of the Pharmacokinetic, Safety and Tolerability of Alpha-1 MP and Prolastin In Adult Alpha1-Antitrypsin Deficient Patients (ChAMP)
This study has been completed.
Study NCT00295061   Information provided by Talecris Biotherapeutics
First Received: February 20, 2006   Last Updated: September 26, 2008   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Estimated Primary Completion Date: No date given
No publications provided by Talecris Biotherapeutics

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Stocks JM, Brantly ML, Wang-Smith L, Campos MA, Chapman KR, Kueppers F, Sandhaus RA, Strange C, Turino G. Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha?-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol. 2010 Sep 30;10:13.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services